Developing Treatment, Treatment Validation, and Treatment Scope in the Setting of an Autism Clinical Trial
Annual rept. 16 Sep 2008-15 Sep 2009
ROBERT WOOD JOHNSON MEDICAL SCHOOL PISCATAWAY NJ
Pagination or Media Count:
During the 01 year we obtained IRB approval, designed primers as per task 8, and wrote and submitted a project for an NIH Center grant to extend this study. We obtained IRB approval on 120709. Our approved protocol and supporting documents have been submitted to the Human Research Protection Office HRPO, Office of Research Protections ORP of the DOD for review. We are also applying for a Certificate of Confidentiality COC from the NIH. Once we have approval from the Human Research Protection Office HRPO, Office of Research Protections ORP of the DOD we will begin work on tasks 4 and 7. We will also begin work on task 6, 9, 10, 11 and 12 for the samples obtained from the AGRE Bank since these samples will be received without PHI and therefore do not need a COC but these tasks will not begin for the recruited study subjects until subject recruitment, enrollment a treatment have been completed. Task 8 was completed in early 2009 but we will re-assess our results since a significant amount of time has passed and there may be better SNPs available at this time. Please see partnering projects W81XWH-08-1-0729 and W81XWH-08-1-0730.
- Medicine and Medical Research